Your browser doesn't support javascript.
loading
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
Fitzal, Florian; Bolliger, Michael; Dunkler, Daniela; Geroldinger, Angelika; Gambone, Luca; Heil, Jörg; Riedel, Fabian; de Boniface, Jana; Andre, Camilla; Matrai, Zoltan; Pukancsik, Dávid; Paulinelli, Regis R; Ostapenko, Valerijus; Burneckis, Arvydas; Ostapenko, Andrej; Ostapenko, Edvin; Meani, Francesco; Harder, Yves; Bonollo, Marta; Alberti, Andrea S M; Tausch, Christoph; Papassotiropoulos, Bärbel; Helfgott, Ruth; Heck, Dietmar; Fehrer, Hans-Jörg; Acko, Markus; Schrenk, Peter; Trapp, Elisabeth K; Gunda, Pristauz-Telsnigg; Clara, Paliczek; Montagna, Giacomo; Ritter, Mathilde; Blohmer, Jens-Uwe; Steffen, Sander; Romics, Laszlo; Morrow, Elizabeth; Lorenz, Katharina; Fehr, Mathias; Weber, Walter Paul.
Afiliação
  • Fitzal F; Department of General Surgery and Breast Health Center, Medical University Vienna, Vienna, Austria. florian.fitzal@meduniwien.ac.at.
  • Bolliger M; Department of General Surgery and Breast Health Center, Medical University Vienna, Vienna, Austria.
  • Dunkler D; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Geroldinger A; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Gambone L; Department of General Surgery and Breast Health Center, Medical University Vienna, Vienna, Austria.
  • Heil J; Departement of Obstetrics and Gynecology, Breast Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Riedel F; Departement of Obstetrics and Gynecology, Breast Center, Heidelberg University Hospital, Heidelberg, Germany.
  • de Boniface J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Andre C; Departemt of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.
  • Matrai Z; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Pukancsik D; Department of Surgery, Uppsala University Hospital, Uppsala, Sweden.
  • Paulinelli RR; Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary.
  • Ostapenko V; Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary.
  • Burneckis A; Federal University of Goiás, Araújo Jorge Hospital, Goiás Anti-Cancer Association, Goiás, Brazil.
  • Ostapenko A; National Cancer Institute Vilnius Lithuania, Vilnius, Lithuania.
  • Ostapenko E; Faculty of Medicine, University of Vilnius, Vilnius, Lithuania.
  • Meani F; National Cancer Institute Vilnius Lithuania, Vilnius, Lithuania.
  • Harder Y; Faculty of Medicine, University of Vilnius, Vilnius, Lithuania.
  • Bonollo M; National Cancer Institute Vilnius Lithuania, Vilnius, Lithuania.
  • Alberti ASM; Faculty of Medicine, University of Vilnius, Vilnius, Lithuania.
  • Tausch C; National Cancer Institute Vilnius Lithuania, Vilnius, Lithuania.
  • Papassotiropoulos B; Faculty of Medicine, University of Vilnius, Vilnius, Lithuania.
  • Helfgott R; Centro di Senologia della Svizzera Italiana (CSSI), Lugano, Switzerland.
  • Heck D; Department of Obstetrics and Gynecology, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
  • Fehrer HJ; Centro di Senologia della Svizzera Italiana (CSSI), Lugano, Switzerland.
  • Acko M; Department of Plastic, Reconstructive and Aesthetic Surgery, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
  • Schrenk P; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
  • Trapp EK; Centro di Senologia della Svizzera Italiana (CSSI), Lugano, Switzerland.
  • Gunda PT; Department of Obstetrics and Gynecology, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
  • Clara P; Centro di Senologia della Svizzera Italiana (CSSI), Lugano, Switzerland.
  • Montagna G; Department of Plastic, Reconstructive and Aesthetic Surgery, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
  • Ritter M; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
  • Blohmer JU; Breast-Center, Zurich, Switzerland.
  • Steffen S; Breast-Center, Zurich, Switzerland.
  • Romics L; Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria.
  • Morrow E; Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria.
  • Lorenz K; Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria.
  • Fehr M; Department of Surgery, Ordensklinikum Linz - Sisters of Charity, Linz, Austria.
  • Weber WP; Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
Ann Surg Oncol ; 29(2): 1061-1070, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34647202
ABSTRACT

INTRODUCTION:

Recent data suggest that margins ≥2 mm after breast-conserving surgery may improve local control in invasive breast cancer (BC). By allowing large resection volumes, oncoplastic breast-conserving surgery (OBCII; Clough level II/Tübingen 5-6) may achieve better local control than conventional breast conserving surgery (BCS; Tübingen 1-2) or oncoplastic breast conservation with low resection volumes (OBCI; Clough level I/Tübingen 3-4).

METHODS:

Data from consecutive high-risk BC patients treated in 15 centers from the Oncoplastic Breast Consortium (OPBC) network, between January 2010 and December 2013, were retrospectively reviewed.

RESULTS:

A total of 3,177 women were included, 30% of whom were treated with OBC (OBCI n = 663; OBCII n = 297). The BCS/OBCI group had significantly smaller tumors and smaller resection margins compared with OBCII (pT1 50% vs. 37%, p = 0.002; proportion with margin <1 mm 17% vs. 6%, p < 0.001). There were significantly more re-excisions due to R1 ("ink on tumor") in the BCS/OBCI compared with the OBCII group (11% vs. 7%, p = 0.049). Univariate and multivariable regression analysis adjusted for tumor biology, tumor size, radiotherapy, and systemic treatment demonstrated no differences in local, regional, or distant recurrence-free or overall survival between the two groups.

CONCLUSIONS:

Large resection volumes in oncoplastic surgery increases the distance from cancer cells to the margin of the specimen and reduces reexcision rates significantly. With OBCII larger tumors are resected with similar local, regional and distant recurrence-free as well as overall survival rates as BCS/OBCI.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Ann Surg Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria